Age Related Macular Degeneration Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
SKU : PH114
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Age-Related Macular Degeneration Market?
Age-Related Macular Degeneration Market is expected to grow at a CAGR of 6.90% during the forecast period 2024-2031.
Who are the Key players contributing to the market's growth?
The Key Players are Novartis, Bayer, Roche, Bausch & Lomb, Allergan, Iconic Therapeutics, Neurotech Pharmaceuticals, Regeneron Pharmaceuticals Inc, Alcon, Santen Pharmaceutical.
Related Reports
pharmaceuticalsXerophthalmia Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 06
Starting from
$4350
pharmaceuticalsOphthalmology Drugs and Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsMacular Degeneration Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsOptical Disorders Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 01
Starting from
$4350
pharmaceuticalsDry Eye Syndrome Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
pharmaceuticalsAMD Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 09
Starting from
$4350